Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.
(Reuters) - Abbott Laboratories (NYSE: ABT) on Wednesday forecast 2025 profit that came in line with Wall Street estimates as ...
Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...
Inc., which was acquired by Abbott Laboratories. Prior to that, Rosenstein was a shareholder at Fredrikson & Byron, where he was a member of the Securities, Corporate and Mergers & Acquisitions ...
Like social media CEO Mark Zuckerberg’s AI ... beating its benchmark by 150 percentage points. (see more details here).
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.